Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1755 | Thyroid cancer | ICEECE2012

The TRHR gene is associated to hypothalamo-pituitary sensitivity to levothyroxine in thyroidectomized patients

Brigante G , Spaggiari G , Cioni K , Gnarini V , Pignatti E , Casarini L , Marino M , Tuttelmann F , Carani C , Simoni M

Background: Patients thyroidectomized for thyroid cancer need variable doses of levothyroxine (LT4) to obtain TSH suppression. A predetermined thyroid function set-point for each individual has been hypothesized, suggesting a genetic influence in the regulation of pituitary-thyroid axis. We hypothesized of the TRHR gene could be associated with a different hypothalamo-pituitary sensitivity to the negative feedback of the thyroid hormones.<p class=...

ea0083rdo2 | Reproductive and Developmental Endocrinology | EYES2022

Ketogenic state is able to improve testosterone serum levels - a meta-analytic approach

C. Furini , G Spaggiari , C. Greco , M. Simoni , D. Santi

Background: It is widely demonstrated that obesity and hypogonadism are bi-directionally correlated, since the hypogonadism prevalence is higher in obese population, while weight loss increases testosterone serum levels. Several approaches are available to contrast weight excess, from simple dietary regimens to more complex surgical procedures. Ketogenic diets (KD) fit in this context and their application is growing year after year, aiming to improve the metabolic and weight ...

ea0083rdo1 | Reproductive and Developmental Endocrinology | EYES2022

Follicle stimulating hormone is efficient in increasing sperm parameters in idiopathic infertility

M. Romeo , G Spaggiari , F Nuzzo , A. R. Granata , M. Simoni , D. Santi

Background: Exogenous follicle-stimulating hormone (FSH) administration in male idiopathic infertility showed the most convincing rationale in the face of a clinical efficacy below expectations. It was calculated that 10 to 18 men have to be treated to achieve one pregnancy.Objectives: To assess the effectiveness of FSH administration in male idiopathic infertility in a clinical setting.Methods: A retrospective real-world study was...

ea0083rdo5 | Reproductive and Developmental Endocrinology | EYES2022

Vascular erectile dysfunction as a mirror of general health: focus on patients comorbidities

B. Rossi , M. Romeo , A. R. Granata , V. Rochira , M. Simoni , G Spaggiari , D. Santi

Background: Erectile dysfunction (ED) is the most frequent sexual disorder. Although psychological ED (pED) is the most frequent form, vascular ED (vED) is associated with 1.25 times greater risk of developing major cardiovascular diseases. Alongside cardiovascular aspect, the evaluation of patientsÂ’ health, measured by the comorbidities number, in relation to the ED aetiology has never been investigated so far.Objectives: To explore the potential r...

ea0083rdo3 | Reproductive and Developmental Endocrinology | EYES2022

Which sperm parameter limits could really guide the clinical decision in assisted reproduction?

L. Dalla Valentina , G Spaggiari , D Morini , B. Melli , L Aguzzoli , M. T. Villani , M. Simoni , D. Santi

Background: The predictive role of sperm motility and morphology was recently detected in a large sample of more than 20000 assisted reproductive technology (ART) fresh cycles. However, the complete ART procedure consisted in both fresh and frozen-embryos transfers and only a comprehensive evaluation of the entire process could really confirm if these parameters really predict the ART success.Aim of the study: To identify predictive parameters of ART suc...

ea0083rdp3 | Reproductive and Developmental Endocrinology | EYES2022

Pharmacodynamics and safety of human recombinant luteinising hormone (LH) in hypogonadotropic hypogonadal men: a new ongoing multicenter study

F. Costantino , G. Spaggiari , L. Dalla valentina , C de Angelis , E Ferrante , C. Furini , F Garifalos , R. Indirli , F Lombardo , G. Mantovani , D Menafra , M Notarianni , F Pallotti , R Pivonello , M. Romeo , M. Simoni , D. Santi

State of the art: In pharmacology, human chorionic gonadotropin (hCG) is considered equivalent to luteinising hormone (LH) since both act on the same receptor. Thus, when testicular function needs to be clinically restored (i.e. in case of hypogonadotropic hypogonadism [HH]), hCG is used instead of LH. However, growing evidences showed LH and hCG activate different molecular pathways and offer different outcomes in women undergoing assisted reproduction. The different action b...